RRF2M_HUMAN - dbPTM
RRF2M_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RRF2M_HUMAN
UniProt AC Q969S9
Protein Name Ribosome-releasing factor 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03059}
Gene Name GFM2 {ECO:0000255|HAMAP-Rule:MF_03059}
Organism Homo sapiens (Human).
Sequence Length 779
Subcellular Localization Mitochondrion .
Protein Description Mitochondrial GTPase that mediates the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. Acts in collaboration with MRRF. GTP hydrolysis follows the ribosome disassembly and probably occurs on the ribosome large subunit. Not involved in the GTP-dependent ribosomal translocation step during translation elongation..
Protein Sequence MLTNLRIFAMSHQTIPSVYINNICCYKIRASLKRLKPHVPLGRNCSSLPGLIGNDIKSLHSIINPPIAKIRNIGIMAHIDAGKTTTTERILYYSGYTRSLGDVDDGDTVTDFMAQERERGITIQSAAVTFDWKGYRVNLIDTPGHVDFTLEVERCLRVLDGAVAVFDASAGVEAQTLTVWRQADKHNIPRICFLNKMDKTGASFKYAVESIREKLKAKPLLLQLPIGEAKTFKGVVDVVMKEKLLWNCNSNDGKDFERKPLLEMNDPELLKETTEARNALIEQVADLDDEFADLVLEEFSENFDLLPAEKLQTAIHRVTLAQTAVPVLCGSALKNKGIQPLLDAVTMYLPSPEERNYEFLQWYKDDLCALAFKVLHDKQRGPLVFMRIYSGTIKPQLAIHNINGNCTERISRLLLPFADQHVEIPSLTAGNIALTVGLKHTATGDTIVSSKSSALAAARRAEREGEKKHRQNNEAERLLLAGVEIPEPVFFCTIEPPSLSKQPDLEHALKCLQREDPSLKVRLDPDSGQTVLCGMGELHIEIIHDRIKREYGLETYLGPLQVAYRETILNSVRATDTLDRTLGDKRHLVTVEVEARPIETSSVMPVIEFEYAESINEGLLKVSQEAIENGIHSACLQGPLLGSPIQDVAITLHSLTIHPGTSTTMISACVSRCVQKALKKADKQVLEPLMNLEVTVARDYLSPVLADLAQRRGNIQEIQTRQDNKVVIGFVPLAEIMGYSTVLRTLTSGSATFALELSTYQAMNPQDQNTLLNRRSGLT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationNLRIFAMSHQTIPSV
CEEEEEECCCCCCEE
14.71-
14PhosphorylationIFAMSHQTIPSVYIN
EEEECCCCCCEEEEC
29.45-
31PhosphorylationCCYKIRASLKRLKPH
HHHHHHHHHHHHCCC
25.28-
84PhosphorylationAHIDAGKTTTTERIL
EEEECCCCCCCCEEE
28.5825404012
85PhosphorylationHIDAGKTTTTERILY
EEECCCCCCCCEEEE
34.9025404012
86PhosphorylationIDAGKTTTTERILYY
EECCCCCCCCEEEEE
31.7125404012
87PhosphorylationDAGKTTTTERILYYS
ECCCCCCCCEEEEEC
22.6025404012
196UbiquitinationPRICFLNKMDKTGAS
CEEEEEECCCCCCCC
51.10-
199UbiquitinationCFLNKMDKTGASFKY
EEEECCCCCCCCHHH
45.41-
203PhosphorylationKMDKTGASFKYAVES
CCCCCCCCHHHHHHH
24.5024719451
205UbiquitinationDKTGASFKYAVESIR
CCCCCCHHHHHHHHH
29.79-
218UbiquitinationIREKLKAKPLLLQLP
HHHHHHCCCEEEECC
34.31-
218 (in isoform 2)Ubiquitination-34.31-
230UbiquitinationQLPIGEAKTFKGVVD
ECCCCCCCCCCCHHH
50.63-
231PhosphorylationLPIGEAKTFKGVVDV
CCCCCCCCCCCHHHH
37.3120068231
233AcetylationIGEAKTFKGVVDVVM
CCCCCCCCCHHHHHH
56.9023749302
233SuccinylationIGEAKTFKGVVDVVM
CCCCCCCCCHHHHHH
56.9027452117
233MalonylationIGEAKTFKGVVDVVM
CCCCCCCCCHHHHHH
56.9026320211
241UbiquitinationGVVDVVMKEKLLWNC
CHHHHHHHEECCCCC
39.84-
241 (in isoform 2)Ubiquitination-39.84-
243UbiquitinationVDVVMKEKLLWNCNS
HHHHHHEECCCCCCC
43.28-
259UbiquitinationDGKDFERKPLLEMND
CCCCCCCCCCCCCCC
32.59-
271AcetylationMNDPELLKETTEARN
CCCHHHHHHHHHHHH
66.6930585809
334MalonylationVLCGSALKNKGIQPL
HHCCHHHHCCCCHHH
57.2226320211
334AcetylationVLCGSALKNKGIQPL
HHCCHHHHCCCCHHH
57.2225953088
336MalonylationCGSALKNKGIQPLLD
CCHHHHCCCCHHHHH
56.6626320211
336UbiquitinationCGSALKNKGIQPLLD
CCHHHHCCCCHHHHH
56.66-
348PhosphorylationLLDAVTMYLPSPEER
HHHHHHHCCCCHHHH
13.19-
373UbiquitinationDLCALAFKVLHDKQR
HHHHHHHHHHHHCCC
37.98-
3782-HydroxyisobutyrylationAFKVLHDKQRGPLVF
HHHHHHHCCCCCEEE
31.02-
390PhosphorylationLVFMRIYSGTIKPQL
EEEEEEECCCCCCEE
27.3926503514
394MalonylationRIYSGTIKPQLAIHN
EEECCCCCCEEEEEE
26.9230639696
394UbiquitinationRIYSGTIKPQLAIHN
EEECCCCCCEEEEEE
26.92-
404 (in isoform 2)Ubiquitination-27.1321906983
426PhosphorylationDQHVEIPSLTAGNIA
CCCCCCCCCCCCCEE
43.97-
451UbiquitinationGDTIVSSKSSALAAA
CCEEECCHHHHHHHH
40.712190698
451MalonylationGDTIVSSKSSALAAA
CCEEECCHHHHHHHH
40.7126320211
483 (in isoform 1)Ubiquitination-5.1221906983
510UbiquitinationPDLEHALKCLQREDP
CCHHHHHHHHHCCCC
33.41-
520UbiquitinationQREDPSLKVRLDPDS
HCCCCCCEEEECCCC
29.64-
551PhosphorylationHDRIKREYGLETYLG
HHHHHHHHCCCCCCC
30.9220068231
555PhosphorylationKREYGLETYLGPLQV
HHHHCCCCCCCCHHH
29.1422210691
556PhosphorylationREYGLETYLGPLQVA
HHHCCCCCCCCHHHH
10.5720068231
564PhosphorylationLGPLQVAYRETILNS
CCCHHHHHHHHHHHH
15.32-
577PhosphorylationNSVRATDTLDRTLGD
HHHHCCCCCCCCCCC
26.6322210691
611PhosphorylationMPVIEFEYAESINEG
EEEEEEEEHHHHCCC
22.46-
614PhosphorylationIEFEYAESINEGLLK
EEEEEHHHHCCCCCH
23.65-
700PhosphorylationEVTVARDYLSPVLAD
EEEEEHHHHHHHHHH
11.9721406692
702PhosphorylationTVARDYLSPVLADLA
EEEHHHHHHHHHHHH
13.5121406692
720PhosphorylationGNIQEIQTRQDNKVV
CCCCEEEECCCCEEE
35.6430377224
741PhosphorylationAEIMGYSTVLRTLTS
HHHCCHHHHHHHHCC
18.3124719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RRF2M_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RRF2M_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RRF2M_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TRIM9_HUMANTRIM9physical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RRF2M_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP